Last reviewed · How we verify

NCT04695938

Craniofacial Imaging With 3D MRI: an Alternative to Ionising Radiation

Status unknown NA Last updated 5 January 2021
What this trial tests

NA trial testing MRI in Craniosynostoses in 80 participants. Status unknown.

Timeline
27 November 2020
Primary endpoint
31 July 2023
31 July 2023

Quick facts

Lead sponsorUniversity of Cambridge
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment80
Start date27 November 2020
Primary completion31 July 2023
Estimated completion31 July 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Cambridge

Who can join

Adults 0 Months to 2, any sex, with Craniosynostoses or Synostosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Craniosynostosis is a condition where infants are born with or subsequently develop an abnormally shaped skull. The skull develops from plates of bone separated from each other by growth lines (sutures). Craniosynostosis refers to early fusion of one or more of these sutures. Whilst in many cases the abnormal head shape provides doctors with the underlying diagnosis, it is necessary to confirm this using imaging. A CT scan involves using multiple x-rays to build a picture of the part of the body being examined. X-rays are associated with potential long term harm, particularly in young children who have longer to incur those risks. MRI uses magnets and radiowaves to create images of the body, and therefore a radiation-free method of imaging. The investigators have previously shown in a pilot group that a specific MRI technique ("Black Bone") can distinguish between normal and prematurely fused cranial sutures, and that the images can be reconstructed in 3D in the same way as CT. The investigators now need to confirm the findings in a larger patient group, and develop automated methods of creating 3D images of the bone. Children in whom there is clinical suspicion of craniosynostosis will be recruited for MRI examination. In children who are already undergoing MRI examination of the head (for any indication), the investigators will add on bone specific sequences. There are no known long term risks associated with MRI, and no contrast medium is required. Anonymised MRI data will be used to further develop our 3D techniques.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Imaging in Craniofacial Disorders With Special Emphasis on Gradient Echo Black-Bone and Zero Time Echo MRI Sequences.
    Ganau M, Syrmos NC, Magdum SA. · · 2022 · cited 4× · PMID 36388002 · DOI 10.4103/jpn.jpn_46_22

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other recruiting trials for Craniosynostoses

Currently open trials in the same condition.

Other University of Cambridge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04695938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing